		<div class="wpcnt">
			<div class="wpa">
				<span class="wpa-about">Advertisements</span>
				<div class="u top_amp">
							<amp-ad width="300" height="265"
		 type="pubmine"
		 data-siteid="111265417"
		 data-section="2">
		</amp-ad>
				</div>
			</div>
		</div><p>A potential coronavirus vaccine being developed in the UK will begin human trials on Thursday.</p>
<p>Health Secretary Matt Hancock made the announcement, saying he is <em>“throwing everything at”</em> the country’s efforts to create a Covid-19 vaccine.</p>
<p>Speaking at the daily Downing Street press conference, he also pledged fresh funding to help increase British work on the process.</p>
<p>Mr Hancock said: <em>“In the long run, the best way to defeat coronavirus is through a vaccine.</em></p>
<p><em>“After all, this is a new disease, this is uncertain science, but I’m certain we will throw everything we’ve got at developing a vaccine.</em></p>
<p><em>“The UK is at the front of the global effort.</em></p>
<p><em>“We have put more money than any other country into a global search for a vaccine and, for all the efforts around the world, two of the leading vaccine developments are taking place here at home – at Oxford and Imperial.</em></p>
<p><em>“Both of these promising projects are making rapid progress and I’ve told the scientists leading them we will do everything in our power to support.”</em></p>
<p>The project at Imperial College London will receive £22.5 million to support its clinical trials and Oxford University will be granted £20 million.</p>
<p>Mr Hancock acknowledged the process for finding a vaccine would take <em>“trial and error”</em>, but told UK scientists leading the search he would <em>“back them to the hilt and give them every resource they need”</em> in order to succeed.</p>
<p><em>“After all, the upside of being the first country in the world to develop a successful vaccine is so huge that I am throwing everything at it,”</em> said Mr Hancock.</p>
<p>Work on the vaccine, developed by clinical teams at the University of Oxford’s Jenner Institute and Oxford Vaccine Group, began in January.</p>
<p>Now a study involving up to 510 healthy volunteers between 18 and 55 is to get under way in Oxford and Southampton, with three further sites likely to be added.</p>
<p>The UK will join only the US – with two studies – and China, in beginning human trials.</p>
<p>Elsewhere researchers at Imperial have developed a candidate which, when injected, will deliver the genetic instructions to muscle cells to make the SARS-CoV-2 spike surface protein.</p>
<p>This should provoke an immune response and create immunity to the virus.</p>
<p>The team, led by Professor Robin Shattock from Imperial’s Department of Infectious Disease, has been testing the candidate in animals since early February.</p>
<p>Clinical trials are expected to begin in June and the team will look to recruit healthy adults to test the vaccine.</p>
<p>Results could be available as soon as September, the researchers say.<br />
The trial is not yet open to recruitment, but will be announced in due course.</p>
			<div style="padding-bottom:15px;" class="wordads-tag" data-slot-type="belowpost">
				<div id="atatags-dynamic-belowpost-68ed0c5140fb6">
					<script type="text/javascript">
						window.getAdSnippetCallback = function () {
							if ( false === ( window.isWatlV1 ?? false ) ) {
								// Use Aditude scripts.
								window.tudeMappings = window.tudeMappings || [];
								window.tudeMappings.push( {
									divId: 'atatags-dynamic-belowpost-68ed0c5140fb6',
									format: 'belowpost',
								} );
							}
						}

						if ( document.readyState === 'loading' ) {
							document.addEventListener( 'DOMContentLoaded', window.getAdSnippetCallback );
						} else {
							window.getAdSnippetCallback();
						}
					</script>
				</div>
			</div>
Discover more from London Glossy Post
Subscribe to get the latest posts sent to your email.
